Scribe Therapeutics SCTX Growth Metrics (2025-2026)

NASDAQ SCTX
$16.86 -0.50 (-2.88%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Scribe Therapeutics Quarterly Growth Metrics

Periods 4 quarters
Latest Jun 2026

Scribe Therapeutics reported revenue growth of -60.84% for the quarter ended Jun 2026. These growth metrics cover 4 quarters of results from Jun 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Jun2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Total Debt (QoQ) 14.73%-6.78%
Share-based Compensation (QoQ)Stock Comp. (QoQ) 0.75%-88.48%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 193.59%-66.42%
Revenue (QoQ) -71.40%-14.11%
Revenue Growth (1y) -86.96%-60.84%
Return on Sales [ROS] (QoQ)ROS (QoQ) -0.02M0.01M
Return on Sales [ROS] Growth (1y)ROS Growth (1y) -0.05M-0.03M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) -8.82%-9.94%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) -27.21%
Operating Margin (QoQ) -0.02M0.01M
Operating Margin Growth (1y) -0.05M-0.03M
Operating Income (QoQ)Op. Inc (QoQ) -109.23%24.40%
Operating Income Growth (1y)Op. Inc Growth (1y) -123.63%19.20%
Net Margin (QoQ) -0.02M0.04M
Net Margin Growth (1y) -0.08M-0.01M
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -189.14%62.66%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -406.48%34.60%
Net Income (QoQ) -189.14%62.66%
Net Income Growth (1y) -406.48%34.60%
Net Cash Flow (QoQ)NCF (QoQ) -153.69%100.46%
Net Cash Flow Growth (1y)NCF Growth (1y) 3.98%488.18%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) -109.23%-63.80%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) -123.63%-75.07%
Income After Tax (QoQ) -144.22%61.65%
Income After Tax Growth (1y) -316.55%34.60%
Free Cash Flow (QoQ)FCF (QoQ) 38.67%28.62%
Free Cash Flow Growth (1y)FCF Growth (1y) 42.59%33.17%
FCF Margin (QoQ) -0.01M0.01M
FCF Margin Growth (1y) -0.03M-0.01M
EPS (Diluted) (QoQ) 63.37%
EPS (Diluted) Growth (1y) 35.83%
EPS (Basic) (QoQ) 63.37%
EPS (Basic) Growth (1y) 35.83%
EBT (QoQ) -183.82%63.40%
EBT Margin (QoQ) -0.02M0.04M
EBT Margin Growth (1y) -0.07M-0.01M
EBT Growth (1y) -357.73%40.98%
EBIT (QoQ) -109.23%24.40%
EBIT Margin (QoQ) -0.02M0.01M
EBIT Margin Growth (1y) -0.05M-0.03M
EBIT Growth (1y) -123.63%19.20%
EBITDA Margin (QoQ) -0.02M0.01M
EBITDA Margin Growth (1y) -0.05M-0.02M
Cash from Operations (QoQ)Cash from Ops. (QoQ) 51.32%29.36%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) 44.53%19.51%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) -87.28%40.95%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) -25.66%723.71%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) 59.28%74.60%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 1.54%
Capital Expenditures (QoQ)Capex (QoQ) 389.41%358.82%
Capital Expenditures Growth (1y)Capex Growth (1y) 96.54%-96.90%
Assets (QoQ) -16.63%-11.17%
Assets Growth (1y) -38.88%

Scribe Therapeutics Growth Metrics API

Pull Scribe Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SCTX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY